Financial Architects (New Jersey)’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-30
| Closed | -$19K | – | 649 |
|
|
2020
Q2 | $19K | Buy |
30
+24
| +400% | +$15.2K | ﹤0.01% | 549 |
|
|
2020
Q1 | $3K | Buy |
+6
| New | +$3K | ﹤0.01% | 755 |
|
|
2019
Q2 | – | Sell |
-26
| Closed | -$11K | – | 1276 |
|
|
2019
Q1 | $11K | Sell |
26
-154
| -86% | -$65.2K | ﹤0.01% | 948 |
|
|
2018
Q4 | $67K | Hold |
180
| – | – | 0.01% | 447 |
|
|
2018
Q3 | $73K | Sell |
180
-100
| -36% | -$40.6K | 0.01% | 468 |
|
|
2018
Q2 | $97K | Hold |
280
| – | – | 0.02% | 411 |
|
|
2018
Q1 | $96K | Buy |
280
+132
| +89% | +$45.3K | 0.02% | 418 |
|
|
2017
Q4 | $56K | Buy |
148
+100
| +208% | +$37.8K | 0.01% | 573 |
|
|
2017
Q3 | $21K | Sell |
48
-29
| -38% | -$12.7K | ﹤0.01% | 853 |
|
|
2017
Q2 | $38K | Hold |
77
| – | – | 0.01% | 674 |
|
|
2017
Q1 | $30K | Sell |
77
-15
| -16% | -$5.84K | 0.01% | 741 |
|
|
2016
Q4 | $34K | Buy |
92
+8
| +10% | +$2.96K | 0.01% | 684 |
|
|
2016
Q3 | $34K | Buy |
84
+56
| +200% | +$22.7K | 0.01% | 683 |
|
|
2016
Q2 | $10K | Buy |
28
+5
| +22% | +$1.79K | ﹤0.01% | 967 |
|
|
2016
Q1 | $8K | Buy |
+23
| New | +$8K | ﹤0.01% | 788 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 734 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 1203 |
|
|
2015
Q1 | – | Hold |
0
| – | – | – | 1001 |
|
|
2014
Q4 | – | Hold |
0
| – | – | – | 989 |
|
|
2013
Q4 | – | Sell |
-150
| Closed | -$47K | – | 459 |
|
|
2013
Q3 | $47K | Buy |
+150
| New | +$47K | 0.03% | 256 |
|